Literature DB >> 33326094

Molecular Approaches to Diagnosis in Ewing Sarcoma: Fluorescence In Situ Hybridization (FISH).

Marcel Trautmann1, Wolfgang Hartmann2.   

Abstract

The differential diagnosis of small round cell tumors (SRCT) crucially relies on the synoptic evaluation of morphology, immunohistochemical patterns, and molecular features. Though the implementation of broad RNA sequencing in diagnostic molecular pathology routines has substantially changed the standards of molecular affirmation of diagnoses, fluorescence in situ hybridization (FISH) on formalin-fixed, paraffin-embedded (FFPE) tissue sections is still an elementary tool to provide a rapid molecular corroboration of diagnoses, essentially required for therapeutic decisions. We discuss here the major FISH approaches currently employed in diagnostic molecular pathology, addressing classic Ewing sarcoma and differential diagnoses among SRCT which cannot sufficiently be ruled out by immunohistochemistry. This chapter will approach technical issues but particularly strategies and pitfalls in the interpretation of FISH patterns.

Entities:  

Keywords:  BCOR; CIC; EWSR1; Ewing sarcoma; FISH; FUS; Small round cell tumor

Mesh:

Substances:

Year:  2021        PMID: 33326094     DOI: 10.1007/978-1-0716-1020-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  36 in total

1.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.

Authors:  O Delattre; J Zucman; B Plougastel; C Desmaze; T Melot; M Peter; H Kovar; I Joubert; P de Jong; G Rouleau
Journal:  Nature       Date:  1992-09-10       Impact factor: 49.962

Review 2.  Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors.

Authors:  Jason L Hornick
Journal:  Mod Pathol       Date:  2014-01       Impact factor: 7.842

3.  Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.

Authors:  Antonio Llombart-Bosch; Isidro Machado; Samuel Navarro; Franco Bertoni; Patrizia Bacchini; Marco Alberghini; Apollon Karzeladze; Nikita Savelov; Semyon Petrov; Isabel Alvarado-Cabrero; Doina Mihaila; Philippe Terrier; Jose Antonio Lopez-Guerrero; Piero Picci
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

4.  A new member of the ETS family fused to EWS in Ewing tumors.

Authors:  M Peter; J Couturier; H Pacquement; J Michon; G Thomas; H Magdelenat; O Delattre
Journal:  Oncogene       Date:  1997-03-13       Impact factor: 9.867

5.  A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.

Authors:  P H Sorensen; S L Lessnick; D Lopez-Terrada; X F Liu; T J Triche; C T Denny
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

6.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Authors:  I S Jeon; J N Davis; B S Braun; J E Sublett; M F Roussel; C T Denny; D N Shapiro
Journal:  Oncogene       Date:  1995-03-16       Impact factor: 9.867

7.  MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.

Authors:  I M Ambros; P F Ambros; S Strehl; H Kovar; H Gadner; M Salzer-Kuntschik
Journal:  Cancer       Date:  1991-04-01       Impact factor: 6.860

8.  The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.

Authors:  Ryo Shibuya; Atsuji Matsuyama; Mitsuhiro Nakamoto; Eisuke Shiba; Takahiko Kasai; Masanori Hisaoka
Journal:  Virchows Arch       Date:  2014-07-17       Impact factor: 4.064

9.  NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.

Authors:  Eleanor Russell-Goldman; Jason L Hornick; Xiaohua Qian; Vickie Y Jo
Journal:  Cancer Cytopathol       Date:  2018-10-30       Impact factor: 5.284

10.  Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis.

Authors:  F Urano; A Umezawa; H Yabe; W Hong; K Yoshida; K Fujinaga; J Hata
Journal:  Jpn J Cancer Res       Date:  1998-07
View more
  1 in total

1.  Establishment of multiplex RT-PCR to detect fusion genes for the diagnosis of Ewing sarcoma.

Authors:  Hitomi Ueno-Yokohata; Hajime Okita; Keiko Nakasato; Chikako Kiyotani; Motohiro Kato; Kimikazu Matsumoto; Nobutaka Kiyokawa; Atsuko Nakazawa; Takako Yoshioka
Journal:  Diagn Pathol       Date:  2021-11-08       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.